Gene Query: MPO

Dataset Description Geneva Score
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 126.38
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 122.68
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 119.23
Expression data from miR340 overexpressing human A549 cells 107.91
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 101.95
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 101.95
Gene expression changes associated with resistance to tagraxofusp (SL-401) 100.4
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 83.47
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 81.85
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 81.4
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 77.2
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 75.89
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 54.48
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 54.32
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 54.32
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 53.18
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 50.92
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 50.92
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 50.08
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 48.1
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 47.77
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 46.28
RNA-seq analysis of AML cells in response to ASLAN003 46.27
MEIS1 regulates hematopoiesis in hPSCs 45.13
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 42.74
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 41.61
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 41.3
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 39.7
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 38.17
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 38.04
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 36.31
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 35.86
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 35.5
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 33.69
A single cell reference map for human blood and tissue T cell activation 30.27
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 30.24
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 28.65
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 28.33
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 27.05
Impact on erythroid progenitor type on erythroid differntiation 25.44
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 24.31
In situ CAPTURE of chromatin interactions by biotinylated dCas9 24.31
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 24.09
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 24.09
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 23.05
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 22.79
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 22.79
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 22.21
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 22.12
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 22.04
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 21.15
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 20.61
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 19.4
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 19.36
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 18.96
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 18.96
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 18.61
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 18.34
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 18.34
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 18.09
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 17.77
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 17.27
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 17.1
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 16.92
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 16.92
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 16.79
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 16.74
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 16.62
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 16.61
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 16.45
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 16.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 15.3
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 15.05
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 15.05
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 13.83
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 13.17
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 13.17
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 12.93
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 12.9
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 12.69
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 12.29
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 12.16
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 11.91
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 11.87
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 11.76
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 11.4
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 11.28
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 11.05
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 10.65
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 10.63
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 10.04
Microglia innatly develop within cerebral organoids 9.66
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 8.61
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 8.52
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 8.25
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 7.95
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 7.95
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 7.64
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.63
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 7.55
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.55
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 7.48
Single-Cell Genotyping of Transcriptomes 7.34
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.34
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 7.19
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 7.13
Short and Long RNA sequencing of human mature erythrocytes 7.01
Human T-cell lymphoblastic lymphoma samples and control thymuses 6.82
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 6.82
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 6.67
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 6.54
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 6.34
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 6.23
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.22
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.12
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.12
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.12
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.07
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.83
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 5.72
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 5.65
Leucegene: ALL sequencing 5.53
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.47
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 5.24
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 5.24
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.2
Epigenomic landscape during organ formation in human early embryos 5.19
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.11
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 5.1
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.94
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.83
RNA-seq analysis of the human fetal kidney. 4.81
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 4.48
Dynamic 3D chromosomal landscapes in acute leukemia 4.28
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 4.28
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 4.08
Bone marrow derived human B cells [normal proB] 4.04
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 3.77
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.76
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.71
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.62
Transcription elongation regulates genome 3D structure 3.22
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.97
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.94
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.94
Dysregulated immune system networks in war veterans with PTSD 2.9
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 2.87
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 2.87
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 2.81
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.75
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.65
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 2.63
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.58
Non-coding regions are the main source of tumor-specific antigens 2.48
Non-coding regions are the main source of tumor-specific antigens [human] 2.48
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 2.44
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 2.44
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 2.43
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 2.3
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.29
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.25
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.25
A map of gene expression in neutrophil-like cell lines 2.23
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 2.18
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 2.18
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.06
BCL11B 2.05
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.05
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 2.04
Measure transcript integrity using RNA-seq data 1.99
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 1.97
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.92
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.92
Targeting MTHFD2 in Acute Myeloid Leukemia 1.88
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.87
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.82
Hepatosplenic T cell lymphoma 1.76
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.76
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 1.65
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 1.61
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.59
LncRNA expression profiling of ischemic stroke patients 1.53
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.46
Transcriptome analysis of CNS leukemia 1.45
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.45
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.41
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.4
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.35
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.35
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.35
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 1.34
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.33
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.29
RNA-seq of primary patient AML samples 1.27
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 1.27
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.26
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 1.22
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.15
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 1.14
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 1.12
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 1.04
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 0.97
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 0.97
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 0.95
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 0.94
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 0.94
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 0.93
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.88
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.84
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.84
RNA sequencing of T-ALL (COG study) 0.82
Analyses of T-ALL (COG study) 0.82
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.81
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 0.8
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 0.8
Transcriptome Profiling of Human Primary Monocytes 0.79
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.79
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 0.76
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 0.75
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.73
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.72
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 0.72
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 0.72
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.64
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.64
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.63
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 0.62
Peptidomimetic blockade of MYB in acute myeloid leukemia 0.62
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 0.62
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.6
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.55
Specific molecular signatures underlie response to decitabine in CMML 0.55
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.54
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.53
RNA-Seq and expression data from human adipose tissue 0.53
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.52
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.52
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.51
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.49
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.48
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.46
The expression profiles of GBC liver metastasis 0.46
Transciptomic profiling of human fetal lung samples 0.45
Aging-associated patterns in the expression of human endogenous retroviruses 0.45
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.43
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 0.4
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.39
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 0.38
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.37
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.36
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.36
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.36
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 0.36
Developmental stage specific chromosome architecture in human erythroid cells 0.36
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.35
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.35
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.35
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 0.34
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.33
Human Treg NaCl stimulation 0.33
quanTIseq: quantifying immune contexture of human tumors 0.33
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.32
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.32
Transcription control by the ENL YEATS domain in acute leukemia 0.31
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 0.31
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.31
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.31
CircRNAome diversity in human mature B-cells, T-cells and monocytes 0.31
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.3
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.29
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.29
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 0.28
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 0.28
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 0.28
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.28
Effects of rFVIIIFc on human macrophages 0.28
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.28
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.27
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.27
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.27
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 0.26
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 0.25
Clinker: visualizing fusion genes detected in RNA-seq data 0.25
CUREfast: Accelerating research with families 0.25
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.25
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.22
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.22
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 0.22
Macrophage Ad5f35 PhenoMap 0.21
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 0.21
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.21
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.21
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 0.2
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 0.2
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 0.2
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.2
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.2
Transcriptome wide analysis of classically and alternatively activated macrophages 0.2
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 0.19
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.18
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 0.17
Intron retention induced by microsatellite expansions as a disease biomarker. 0.17
Macrophage Ad5f35 M2 Challenge 0.16
Expression analysis of the TAF1 syndrome 0.16
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 0.16
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.16
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.16
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.15
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 0.15
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.14
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.14
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 0.14
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 0.14
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 0.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 0.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 0.14
oxLDL exposed trained monocytes 0.14
Transcriptomes of oxLDL exposed trained monocytes 0.14
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 0.14
RNA-seq analysis of differentiating human erythroblasts 0.13
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 0.13
Noncoding regions are the main source of targetable tumor-specific antigens 0.13
Integrating single-cell transcriptomic data across different conditions, technologies, and species 0.13
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.12
MicroRNA-125a-5p overexpression in human macrophages 0.12
Transcriptional profile in human S. haematobium infection 0.12
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.12
Transcriptomes in healthy and CHB fetal hearts 0.12
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.12
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 0.12
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.12
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.12
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 0.12
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 0.12
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 0.12
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 0.11
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.11
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.11
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 0.1
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.1
Reassessment of Exosome Composition 0.1
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 0.1
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 0.1
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.1
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.1
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.1
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.09
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 0.09
Direct Isolation and Characterization of Human Nephron Progenitors. 0.08
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 0.08
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.08
Seletive inhibition of CDK9 in DLBCL cell lines 0.08
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.08
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 0.08
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.08
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.08
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 0.08
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.08
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 0.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 0.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 0.08
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.08
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.08
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.08
HEK293 Heat-shock experiment 0.07
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.07
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.07
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 0.07
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 0.07
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.07
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 0.07
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.07
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 0.07
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.07
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 0.07
Reprogrammed myeloid cell transcriptomes in NSCLC 0.07
Targeted enhancer activation by a subunit of the integrator complex 0.07
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.07
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 0.06
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 0.06
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.06
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 0.06
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.06
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.06
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.06
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 0.06
Transcriptome analysis of SKI knock-out in HL60 cells 0.06
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.06
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 0.06
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 0.06
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.06
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.06
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.05
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.05
Tpl-2 small molecule project 0.05
Tpl-2 and MEK small molecule inhibitors 0.05
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.05
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 0.05
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 0.05
The interplay between SOX4 and SMAD3 in the context of breast cancer 0.05
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 0.05
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.05
circRNA-sequencing 0.05
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.04
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.04
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.04
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.04
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.04
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.04
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.04
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 0.04
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 0.04
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.04
The cytokine environment influence on human skin-derived T cells 0.04
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.04
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.04
Preclinical model of obesity and ER-positive breast cancer 0.04
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 0.04
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 0.04
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 0.04
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 0.04
The transcriptome of Kawasaki Disease arteritis 0.03
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.03
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.03
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.03
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.03
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 0.03
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.03
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.03
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.03
Hepatic transcriptome of pediatric hepatoblastoma. 0.03
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 0.03
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.03
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.03
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.03
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.03
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.03
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.03
Common inflammatory pathways between NEC and Crohn's disease 0.03
RNA m5C Methylation in breast cancer using MeRIP-Seq 0.03
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.03
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.02
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.02
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 0.02
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  0.02
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 0.02
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.02
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.02
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 0.02
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.02
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.02
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.02
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.02
SOX11 knockdown in B-ALL cell lines 0.02
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.02
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.02
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.02
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.02
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 0.02
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.02
Total RNA-Seq data from leukemic patients with complex structural variants 0.02
Effect of disulfiram treatment on pediatric high grade glioma 0.02
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.02
RNA-seq of SCLC PDX models treated with EP 0.02
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.02
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.02
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.01
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.01
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 0.01
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.01
Trascriptome of thyroid cancer-induced macrophages 0.01
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.01
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.01
Transcriptome of Stabilin-1 siRNA transfected human monocytes 0.01
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.01
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.01
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.01
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.01
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.01
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.01
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.01
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.01
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.01
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.01
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.01
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.0
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.0
Human Treg IL-12 stimulation 0.0
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 0.0
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.0
RNA-sequencing of formalin fixed human primary melanoma tissue 0.0
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.0
Transcriptomic analysis of human macrophages in 3D 0.0
Transcriptome analysis of peripheral blood monocytes 0.0
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation